First-lineBetnesol
Betamethasone
Long-acting corticosteroid
Antenatal corticosteroid for fetal lung maturation 24–34⁺⁶ weeks.
IM
First-line for
- Threatened preterm birth 24–34⁺⁶ weeks
- Planned preterm CS up to 38⁺⁶ weeks (consider)
Mechanism
Crosses placenta → glucocorticoid receptor → ↑ surfactant production, alveolar maturation, ↓ IVH, NEC.
“12-12-24-7”
- 12 mg IM × 2 doses 24 h apart
- Maximal effect 24 h–7 days after first dose
- Single rescue if <34 wks & >7 days since first course
Dosing
- Course
- 12 mg IM, 2 doses 24 h apart
Contraindications
- AbsoluteActive systemic infection (e.g. TB, chorioamnionitis — relative)
- CautionMaternal diabetes — expect 24–72 h hyperglycaemia
Side effects
- Maternal hyperglycaemia
- Transient ↓ fetal movements & HRV
- Maternal pulmonary oedema (with tocolytics)
Fetal & maternal notes
- • Reduces neonatal mortality by ~30%.
- • Repeat courses not routinely recommended — single rescue only.
Key interactions
Insulin
CautionHyperglycaemia — increase insulin 24–72 h
Tocolytics + fluids
AvoidPulmonary oedema risk
Clinical pearls
- 💡 Counsel about ↓ fetal movements for 48 h.
- 💡 Do not delay delivery solely to complete course in severe pre-eclampsia.
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.